Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study.

Saved in:
Bibliographic Details
Title: Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study.
Authors: Camporesi S; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; Department of psychiatry and Emergency Department, Geneva University Hospital, Geneva, Switzerland., Xin L; Center for Biomedical Imaging, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Golay P; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Eap CB; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland., Cleusix M; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Cuenod M; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Fournier M; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan., Jenni R; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Ramain J; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; Training and Research Institute in Mental Health (IFRSM), Neuchâtel Centre of Psychiatry, Neuchâtel, Switzerland., Restellini R; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; Emergency medicine department, Geneva University Hospital, Geneva, Switzerland., Solida A; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.; Psychiatry Department for Adults 2, Neuchâtel Centre of Psychiatry, Prefargier, Switzerland., Conus P; Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Do KQ; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland., Khadimallah I; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland. ines.khadimallah@chuv.ch.; Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, Switzerland. ines.khadimallah@chuv.ch.
Source: Molecular psychiatry [Mol Psychiatry] 2024 Nov; Vol. 29 (11), pp. 3669-3679. Date of Electronic Publication: 2024 Jun 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5578
DOI:10.1038/s41380-024-02631-4